U.S. Markets closed

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
19.63+1.09 (+5.88%)
At close: 04:00PM EDT
20.16 +0.53 (+2.70%)
After hours: 06:29PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.58
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 378.92
52 Week Low 317.01
50-Day Moving Average 331.57
200-Day Moving Average 348.40

Share Statistics

Avg Vol (3 month) 3333.3k
Avg Vol (10 day) 3388.85k
Shares Outstanding 525.3M
Implied Shares Outstanding 6N/A
Float 823.94M
% Held by Insiders 14.91%
% Held by Institutions 188.61%
Shares Short (Apr 28, 2022) 41.32M
Short Ratio (Apr 28, 2022) 42.71
Short % of Float (Apr 28, 2022) 46.03%
Short % of Shares Outstanding (Apr 28, 2022) 45.03%
Shares Short (prior month Mar 30, 2022) 41.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin -33.26%
Operating Margin (ttm)-42.60%

Management Effectiveness

Return on Assets (ttm)-5.55%
Return on Equity (ttm)-7.56%

Income Statement

Revenue (ttm)94.08M
Revenue Per Share (ttm)3.74
Quarterly Revenue Growth (yoy)44.70%
Gross Profit (ttm)78.26M
EBITDA -38.63M
Net Income Avi to Common (ttm)-31.29M
Diluted EPS (ttm)-1.24
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)329.63M
Total Cash Per Share (mrq)12.97
Total Debt (mrq)8.31M
Total Debt/Equity (mrq)2.02
Current Ratio (mrq)14.22
Book Value Per Share (mrq)16.28

Cash Flow Statement

Operating Cash Flow (ttm)-18.98M
Levered Free Cash Flow (ttm)-5.04M